Skip to content

Evaluation of gastric conduit perfusion with near infrared fluorescence imaging during esophagectomy: a pilot study

Evaluation of gastric conduit perfusion with near infrared fluorescence imaging during esophagectomy: a pilot study - EGAPERF (Evaluation of GAstric conduit PERFusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46607
Enrollment
70
Registered
2018-03-08
Start date
2018-03-08
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients scheduled for a minimal invasive (or open) esophagectomy for esophageal cancer with a gastric conduit reconstruction - Aged 18 years or older - Signed informed consent.

Exclusion criteria

Exclusion criteria: - Known pregnancy or breastfeeding - Known iodine, shellfish or ICG hypersensitivity - Known hyper-thyroidism - Known liver or renal insufficiency - Unable to provide informed consent

Design outcomes

Primary

MeasureTime frame
- Visualization of the perfusion of the gastric conduit and wash-in and wash-out time of the ICG just before reconstruction of the anastomosis. - Visualization of the perfusion of the anastomotic site after reconstruction of the anastomosis, also measuring the wash-in and wash-out time of the ICG. - Postoperative anastomotic leakage. Anastomotic leakage is defined as clinical suspicion and confirmation by CT-scan of contrast, methylene blue, saliva or other ingested material into the drain or signs of anastomotic leakage during re-intervention or autopsy.

Secondary

MeasureTime frame
- Monitor the procedure time; the total time of the chirurgical procedure is measured. - Complications due to NIRF imaging with ICG

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)